๐๏ธ Verified NIH Record โข Updated 2025-05-16
Parkinson's Foundation PD GENEration Genetic Registry (NCT04994015)
๐ข Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: Parkinson's Foundation
๐ฉบ Plain-English Summary (8th-Grade Level)
Development of a central repository for PD-related genomic data for future research.
Who can join: Review the eligibility criteria below.
Location: University of Alabama Birmingham โ Birmingham, Alabama
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (56 Sites)
Showing the first 25 of 56 sites.
- University of Alabama Birmingham โ Birmingham, Alabama
- MD First Research โ Chandler, Arizona
- Barrow Neurological Institute โ Phoenix, Arizona
- University of Arkansas โ Fayetteville, Arkansas
- University of California San Diego (UCSD) โ La Jolla, California
- University of California Los Angeles โ Los Angeles, California
- University of California San Francisco (UCSF) โ San Francisco, California
- University of Colorado Anschutz โ Aurora, Colorado
- Hartford Healthcare โ Hartford, Connecticut
- Aventura Neurology - Visionary Investigators Network โ Aventura, Florida
- Parkinson's Disease & Movement Disorder Center of Boca Raton โ Boca Raton, Florida
- University of Florida โ Gainesville, Florida
- University of Miami โ Miami, Florida
- Cleveland Clinic Weston โ Weston, Florida
- Morehouse College โ Atlanta, Georgia
- The Queen's Health System โ Honolulu, Hawaii
- University of Illinois-Chicago โ Chicago, Illinois
- Rush University โ Chicago, Illinois
- University of Chicago โ Chicago, Illinois
- Northwestern University โ Evanston, Illinois
- Indiana University โ Indianapolis, Indiana
- University of Iowa โ Iowa City, Iowa
- University of Kansas โ Lawrence, Kansas
- University of Kentucky โ Lexington, Kentucky
- Louisiana State University โ Shreveport, Louisiana
๐ Contact the Study Coordinator
Phone: (800) 473-4636
Email: kghosh@parkinson.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Parkinson's Disease
- Genotypic Influences on Network Progression in Parkinson's Disease โ Manhasset, New York
- Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations โ Phoenix, Arizona
- Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease โ New Haven, Connecticut
- Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD โ Phoenix, Arizona
- Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS โ Lexington, Kentucky
- ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease โ Toronto, Ontario
Explore by condition: All Parkinson's Disease clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.